Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Not Applicable

Recruiting

• Conditions: Substance-Related Disorders; Treatment Adherence
• Interventions: Behavioral: Intake as Usual (IAU); Behavioral: Motivational Interviewing at Intake (MII)

• Registration Number: NCT05489068
• Lead Sponsor: University of New Mexico

Brief Summary

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-16
• Study First Submitted: 2022-07-26
• Study First Submitted QC: 2022-08-02
• Study First Posted: 2022-08-05
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-08
• Last Update Posted: 2025-05-14
• Primary Completion: 2026-10-01
• Study Completion: 2026-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intake as Usual (IAU)	Intake as Usual (IAU)	Clients allocated to the IAU condition will receive the 90-minute standard assessment that is delivered to all clients entering intensive outpatient program (IOP)/outpatient program (OP).
Motivational Interviewing at Intake (MII)	Motivational Interviewing at Intake (MII)	Clients allocated to the MII condition will receive a 90-minute pure Motivational Interviewing (MI) session.

Primary Outcome Measures

Name	Time	Method
Number of participants who attended the first outpatient treatment program session based on electronic medical record review	up to 36 weeks	Treatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session
Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review	up to 36 weeks	Number of treatment sessions that clients attend is determined by review of electronic medical record and calculating number of treatment sessions attended.
Number of participants who completed the three-month outpatient treatment program based on electronic medical record review	up to 36 weeks	Completion of the three-month outpatient treatment program is determined by review of electronic medical record

Secondary Outcome Measures

Name	Time	Method
Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake	1 hour post-intake	The WAI is a validated, self-report measure of client perceptions of the therapeutic process by assessing three sub scales: Goals, Bond, and Tasks. Possible scores on sub scales range from 12 to 84 with higher scores indicative of better therapeutic alliance.
Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intake	baseline and 1 hour post-intake	The URICA is a validated, self-report measure of client readiness for treatment engagement. Possible scores range from 32 to 160 with higher scores indicative greater readiness to enter treatment. Change = (Hour 1 score - Baseline Score).

Trial Locations

Locations (1)

Turning Point Recovery Center; 🇺🇸 Albuquerque, New Mexico, United States